Weibin Zhang

3PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 05, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.

Yan Zhou, Qingcheng Yang, Yang Dong

|Feb 09, 2021
Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma.

Zhuochao Liu, Hongyi Wang, Chuanzhen Hu

Pageof 1